Exclusive Interview with PharmaShots: Kevin Cammack and Mark Warren Share Insight on Lyumjev U-100 Approved for Use in Insulin Pumps

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly, and Mark Warren, MD, Director of Endocrine Clinical Trials and Laboratory Services, Physicians East share their views on the US FDA’s approval of rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2…